Dr. Guillermo Moreno-Sanz

Dr. Guillermo Moreno-Sanz has authored more than 30 scientific articles and 3 patents describing the role of the endocannabinoid system in pain perception. Graduated in Biochemistry and Organic Chemistry from the University of Zaragoza, he obtained his PhD in Neuroscience from the Complutense University of Madrid, in Spain. He gained extensive international experience with long-term fellowships in the Netherlands, Italy, and the United States, developing most of his academic career at the University of California, Irvine, where he discovered a new class of cannabinoid analgesic, currently under clinical development. In 2017, he acted as a consultant to the National Academies of Sciences of the United States in the preparation of the report “The health effects of cannabis and cannabinoids” and founded his consulting firm, Abagune Research, to offer scientific advice and R&D solutions to the international cannabis industry. In 2020 he assumed the scientific and medical direction of Khiron Life Sciences in Europe.